Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 484,600 | 736,600 | 1,810,100 | 1,812,500 | 1,057,300 |
| Depreciation Amortization | 317,400 | 158,700 | 597,500 | 460,800 | 297,600 |
| Income taxes - deferred | -175,900 | -221,800 | 772,400 | 97,800 | 136,100 |
| Accounts receivable | N/A | N/A | -240,800 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -173,400 | N/A | N/A |
| Other Working Capital | -369,000 | 300 | -1,291,000 | -717,700 | -599,600 |
| Other Operating Activity | 1,221,800 | 131,000 | 1,394,700 | 667,700 | 629,800 |
| Operating Cash Flow | $1,478,900 | $804,800 | $2,869,500 | $2,321,100 | $1,521,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,337,800 | 2,085,600 | -1,119,000 | -629,400 | -47,000 |
| PPE Investments | -619,900 | -242,200 | -1,877,600 | -1,428,100 | -971,700 |
| Net Acquisitions | N/A | N/A | -71,700 | -71,700 | -71,700 |
| Purchase Of Investment | -218,100 | -139,800 | -11,967,700 | -3,270,300 | -2,106,500 |
| Sale Of Investment | 270,800 | 187,500 | 14,849,300 | 2,882,700 | 1,737,400 |
| Other Investing Activity | -145,100 | -67,600 | -498,100 | -203,100 | -60,500 |
| Investing Cash Flow | $625,500 | $1,823,500 | $-684,800 | $-2,719,900 | $-1,520,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,791,900 | -1,788,200 | 1,478,200 | 1,218,200 | 324,100 |
| Debt Issued | -94,000 | -97,100 | 1,000,000 | 73,200 | N/A |
| Debt Repayment | N/A | N/A | -839,200 | N/A | N/A |
| Common Stock Issued | 34,900 | 12,500 | 117,900 | 88,900 | 75,800 |
| Dividend Paid | -821,200 | -413,200 | -1,539,800 | -1,154,300 | -769,200 |
| Other Financing Activity | 7,900 | 900 | -13,400 | 0 | -4,700 |
| Financing Cash Flow | $-2,664,300 | $-2,285,100 | $203,700 | $226,000 | $-374,000 |
| Exchange Rate Effect | -163,000 | -100,800 | 220,600 | -6,100 | 13,200 |
| Beginning Cash Position | 5,365,300 | 5,365,300 | 2,756,300 | 2,756,300 | 2,756,300 |
| End Cash Position | 4,642,400 | 5,607,700 | 5,365,300 | 2,577,400 | 2,396,700 |
| Net Cash Flow | $-722,900 | $242,400 | $2,609,000 | $-178,900 | $-359,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,478,900 | 804,800 | 2,869,500 | 2,321,100 | 1,521,200 |
| Capital Expenditure | -619,900 | -242,200 | -1,898,100 | -1,428,100 | -971,700 |
| Free Cash Flow | 859,000 | 562,600 | 971,400 | 893,000 | 549,500 |